Bambusa Therapeutics (BBTX), developer of bispecific antibody therapies, and Aspen Neuroscience (ASPE), a cell therapy developer focused on Parkinsonâs disease, traded lower on Friday as their shares made listing debuts on Nasdaq.
Boston-based Bambusa started trading at $14.88 at about 11.00 To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser